Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
TROW
|
Alan D Wilson |
BUY
Grant, award, or other acquisition
|
Direct | 159 Added 0.77% |
$24,343
$153.1 p/Share
|
Mar 30
2022 |
|
SLB
|
Claudia Jaramillo
VP, Treasurer |
SELL
Open market or private sale
|
Direct | 11,628 Reduced 21.89% |
$500,004
$43.0 p/Share
|
Mar 30
2022 |
|
PXD
|
Neal H Shah
EVP and CFO |
SELL
Open market or private sale
|
Direct | 3,500 Reduced 15.3% |
$899,395
$256.97 p/Share
|
Mar 30
2022 |
|
PXD
|
Mark Stephen Berg
EVP, Corporate Operations |
SELL
Open market or private sale
|
Indirect | 2,500 Reduced 12.71% |
$641,750
$256.7 p/Share
|
Mar 30
2022 |
|
PXD
|
Chris J Cheatwood
EVP, Advisor to Management |
SELL
Open market or private sale
|
Direct | 4,653 Reduced 9.74% |
$1,196,705
$257.19 p/Share
|
Mar 30
2022 |
|
EOG
|
William R. Thomas
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 29,891 Reduced 4.05% |
$3,619,501
$121.09 p/Share
|
Mar 30
2022 |
|
TGT
|
Douglas M Baker Jr
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 1,675 Reduced 4.85% |
$373,960
$223.26 p/Share
|
Mar 30
2022 |
|
TGT
|
Douglas M Baker Jr
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 5,570 Added 13.88% |
$373,858
$67.12 p/Share
|
Mar 30
2022 |
|
SYK
|
Srikant M. Datar
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 826 Reduced 16.35% |
$225,473
$272.97 p/Share
|
Mar 30
2022 |
|
SYK
|
Srikant M. Datar
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 3,520 Added 41.06% |
$225,315
$64.01 p/Share
|
Mar 30
2022 |
|
SO
|
Greene Kimberly S,
Chairman, President & CEO, GPC |
SELL
Open market or private sale
|
Direct | 3,015 Reduced 2.39% |
$218,588
$72.5 p/Share
|
Mar 30
2022 |
|
SO
|
Greene Kimberly S,
Chairman, President & CEO, GPC |
BUY
Exercise of conversion of derivative security
|
Direct | 3,015 Added 2.36% |
-
|
Mar 30
2022 |
|
RCG
|
Murray Stahl
President/Co-Portfolio Manager |
BUY
Open market or private purchase
|
Indirect | 675 Added 0.2% |
$1,620
$2.4 p/Share
|
Mar 30
2022 |
|
SMM
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 53,067 Added 1.41% |
$437,803
$8.25 p/Share
|
Mar 30
2022 |
|
VFL
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 46,609 Added 1.83% |
$581,214
$12.47 p/Share
|
Mar 30
2022 |
|
FHI
|
Thomas R Donahue
VP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 4.72% |
$1,025,400
$34.18 p/Share
|
Mar 30
2022 |
|
SPRO
|
Aquilo Capital Management, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 50,000 Added 0.47% |
$439,500
$8.79 p/Share
|
Mar 30
2022 |
|
PRPL
|
Coliseum Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect | 650,000 Added 2.06% |
$4,205,500
$6.47 p/Share
|
Mar 30
2022 |
|
FET
|
Scf Partners, Inc. |
SELL
Open market or private sale
|
Indirect | 29,479 Reduced 13.45% |
$724,299
$24.57 p/Share
|
Mar 30
2022 |
|
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Direct | 3 Added 0.18% |
$4,351
$1450.35 p/Share
|
Mar 30
2022 |
|
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Indirect | 17 Added 0.05% |
$24,656
$1450.35 p/Share
|
Mar 30
2022 |
|
CVS
|
Prem S Shah
EVP and Group President |
SELL
Open market or private sale
|
Direct | 5,346 Reduced 8.3% |
$559,726
$104.7 p/Share
|
Mar 30
2022 |
|
CVS
|
Prem S Shah
EVP and Group President |
BUY
Exercise of conversion of derivative security
|
Direct | 5,346 Added 7.66% |
$546,682
$102.26 p/Share
|
Mar 30
2022 |
|
LLY
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 0.0% |
$730,075
$292.03 p/Share
|
Mar 30
2022 |
|
CRM
|
Marc Benioff
Chair and CEO |
SELL
Open market or private sale
|
Direct | 2,300 Reduced 0.01% |
$498,088
$216.56 p/Share
|
Mar 30
2022 |
|
CRM
|
Marc Benioff
Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 2,300 Added 0.01% |
$186,277
$80.99 p/Share
|
Mar 30
2022 |
|
SKKY
|
Paul E Thomas
PRESIDENT |
BUY
Open market or private purchase
|
Direct | 5,000 Added 0.1% |
$1,000
$0.2 p/Share
|
Mar 30
2022 |
|
ASMB
|
John G Mc Hutchison |
SELL
Open market or private sale
|
Direct | 4,614 Reduced 2.2% |
$10,012
$2.17 p/Share
|
Mar 30
2022 |
|
ASMB
|
Jason A Okazaki
CEO and President |
SELL
Open market or private sale
|
Direct | 1,269 Reduced 1.32% |
$2,754
$2.17 p/Share
|
Mar 30
2022 |
|
ASMB
|
William E Iv Delaney
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 1,038 Reduced 1.31% |
$2,252
$2.17 p/Share
|
Mar 30
2022 |
|
ASMB
|
Luisa M Stamm
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 1,038 Reduced 2.51% |
$2,252
$2.17 p/Share
|
Mar 30
2022 |
|
ASMB
|
Michael P. Samar
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 2,285 Reduced 2.89% |
$4,958
$2.17 p/Share
|
Mar 30
2022 |
|
TELA
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect | 2,645 Added 0.08% |
$30,814
$11.65 p/Share
|
Mar 30
2022 |
|
ENDP
|
Blaise Coleman
President, CEO |
SELL
Exercise of conversion of derivative security
|
Direct | 89,663 Reduced 6.26% |
-
|
Mar 30
2022 |
|
ENDP
|
Blaise Coleman
President, CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 10,137 Reduced 2.35% |
$25,545
$2.52 p/Share
|
Mar 30
2022 |
|
ENDP
|
Blaise Coleman
President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 35,910 Added 7.67% |
-
|
Mar 30
2022 |
|
ENDP
|
Mark T. Bradley
EVP, Chief Financial Officer |
SELL
Exercise of conversion of derivative security
|
Direct | 26,805 Reduced 10.01% |
-
|
Mar 30
2022 |
|
ENDP
|
Mark T. Bradley
EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,057 Reduced 2.92% |
$7,704
$2.52 p/Share
|
Mar 30
2022 |
|
ENDP
|
Mark T. Bradley
EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 10,735 Added 9.31% |
-
|
Mar 30
2022 |
|
ENDP
|
Matthew Joseph Maletta
EVP, CLO & Company Secretary |
SELL
Exercise of conversion of derivative security
|
Direct | 85,927 Reduced 17.07% |
-
|
Mar 30
2022 |
|
ENDP
|
Matthew Joseph Maletta
EVP, CLO & Company Secretary |
SELL
Payment of exercise price or tax liability
|
Direct | 10,179 Reduced 2.82% |
$25,651
$2.52 p/Share
|
Mar 30
2022 |
|
ENDP
|
Matthew Joseph Maletta
EVP, CLO & Company Secretary |
BUY
Exercise of conversion of derivative security
|
Direct | 34,414 Added 8.7% |
-
|
Mar 30
2022 |
|
ENDP
|
Patrick A Barry
EVP & Pres,Global Comm Ops |
SELL
Exercise of conversion of derivative security
|
Direct | 42,341 Reduced 12.86% |
-
|
Mar 30
2022 |
|
ENDP
|
Patrick A Barry
EVP & Pres,Global Comm Ops |
SELL
Payment of exercise price or tax liability
|
Direct | 4,975 Reduced 2.85% |
$12,537
$2.52 p/Share
|
Mar 30
2022 |
|
ENDP
|
Patrick A Barry
EVP & Pres,Global Comm Ops |
BUY
Exercise of conversion of derivative security
|
Direct | 16,957 Added 8.85% |
-
|
Mar 30
2022 |
|
NGS
|
John Chisholm |
SELL
Open market or private sale
|
Direct | 700 Reduced 6.09% |
$8,127
$11.61 p/Share
|
Mar 30
2022 |
|
OCN
|
John V. Britti
EVP & Chief Investment Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 3,000 Reduced 15.05% |
-
|
Mar 30
2022 |
|
OCN
|
John V. Britti
EVP & Chief Investment Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 3,000 Added 13.08% |
-
|
Mar 30
2022 |
|
OCN
|
Scott William Anderson
EVP & Chief Servicing Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 3,333 Reduced 19.99% |
-
|
Mar 30
2022 |
|
OCN
|
Scott William Anderson
EVP & Chief Servicing Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 3,333 Added 16.66% |
-
|
Mar 30
2022 |